A self-reported inhibitor of metallo-carbapenemases for reversing carbapenem resistance

Int J Biol Macromol. 2023 Dec 1:252:126441. doi: 10.1016/j.ijbiomac.2023.126441. Epub 2023 Aug 20.

Abstract

Metallo-carbapenemases-mediated carbapenem-resistant Enterobacterales (CREs) has been acknowledged as "urgent threat" by the World Health Organization. The discovery of new strategies that block metallo-carbapenemases activity to reverse carbapenem resistance is an urgent need. In this study, a coumarin copper complex containing a PEG linker and glucose ligand, GluC-Cu, was used to reverse carbapenem resistance. Interestingly, it could effectively inhibit metallo-carbapenemases (NDM-1, IMP-1 and ImiS) with an IC50 value in the range of 0.23-1.21 μM, and simultaneously release the green fluorescence signal (GluC), therefore exhibiting self-reported inhibition performance. The inhibition mechanism of oxidizing Zn(II) thiolate site of NDM-1 from Cu2+ to Cu+ was verified by fluorescence assay, HR-MS, and XPS. Moreover, GluC-Cu in combination with meropenem showed excellent synergistic antibacterial effect to effectively combat E. coli expressing metallo-carbapenemases in vitro and in a mice infection model. This bifunctional metallo-carbapenemases inhibitor provides a novel chemical tool to overcome carbapenem resistance.

Keywords: Bacterial resistance; Metallo-carbapenemases; Self-reported inhibitor.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Carbapenems / pharmacology
  • Copper* / pharmacology
  • Escherichia coli*
  • Humans
  • Mice
  • Microbial Sensitivity Tests
  • Self Report
  • beta-Lactamases

Substances

  • carbapenemase
  • Copper
  • Anti-Bacterial Agents
  • beta-Lactamases
  • Carbapenems